SOLENO THERAPEUTICS INC financial data

Symbol
SLNO on Nasdaq
Location
Redwood City, CA
Fiscal year end
31 December
Latest financial report
10-K - Q4 2025 - 25 Feb 2026

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 1155% % -33%
Debt-to-equity 28% % 57%
Return On Equity 5.9% %
Return On Assets 4.6% %

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 51,624,384 shares 2.4%
Common Stock, Shares, Outstanding 52,286,881 shares 14%
Entity Public Float $4,100,000 USD -100%
Common Stock, Value, Issued $52,000 USD 13%
Weighted Average Number of Shares Outstanding, Basic 50,817,586 shares 26%
Weighted Average Number of Shares Outstanding, Diluted 52,384,886 shares 30%

Income Statement

Label TTM Value / Value Unit Change %
Cost of Revenue $1,141,000 USD
Research and Development Expense $40,627,000 USD -48%
General and Administrative Expense $105,861,000 USD 685%
Costs and Expenses $43,913,000 USD -45%
Operating Income (Loss) $9,414,000 USD
Nonoperating Income (Expense) $11,476,000 USD -2.9%
Net Income (Loss) Attributable to Parent $20,890,000 USD
Earnings Per Share, Basic 0.4 USD/shares
Earnings Per Share, Diluted 0.39 USD/shares

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value $70,106,000 USD -20%
Marketable Securities, Current $235,366,000 USD 16%
Accounts Receivable, after Allowance for Credit Loss, Current $28,208,000 USD
Inventory, Net $15,024,000 USD
Assets, Current $355,814,000 USD 21%
Property, Plant and Equipment, Net $185,000 USD -0.54%
Operating Lease, Right-of-Use Asset $2,191,000 USD -22%
Intangible Assets, Net (Excluding Goodwill) $4,861,000 USD -29%
Other Assets, Noncurrent $163,000 USD 96%
Assets $563,830,000 USD 70%
Accounts Payable, Current $12,435,000 USD 40%
Employee-related Liabilities, Current $9,677,000 USD 103%
Liabilities, Current $61,363,000 USD 227%
Operating Lease, Liability, Noncurrent $1,964,000 USD -21%
Other Liabilities, Noncurrent $525,000 USD 2400%
Liabilities $113,715,000 USD 32%
Accumulated Other Comprehensive Income (Loss), Net of Tax $415,000 USD 15%
Retained Earnings (Accumulated Deficit) $431,370,000 USD 4.6%
Stockholders' Equity Attributable to Parent $450,115,000 USD 84%
Liabilities and Equity $563,830,000 USD 70%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities $32,752,000 USD -161%
Net Cash Provided by (Used in) Financing Activities $3,218,000 USD 243%
Net Cash Provided by (Used in) Investing Activities $22,937 USD
Common Stock, Shares Authorized 100,000,000 shares 0%
Common Stock, Shares, Issued 52,286,881 shares 14%
Common Stock, Par or Stated Value Per Share 0.001 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect $6,597,000 USD 95%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $70,106,000 USD -20%
Interest Paid, Excluding Capitalized Interest, Operating Activities $805,000 USD
Deferred Tax Assets, Valuation Allowance $79,905,000 USD -4.3%
Deferred Tax Assets, Gross $81,743,000 USD -4.4%
Operating Lease, Liability $2,690,000 USD -10%
Payments to Acquire Property, Plant, and Equipment $5,000 USD -55%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent $20,944,000 USD
Lessee, Operating Lease, Liability, to be Paid $3,160,000 USD -15%
Property, Plant and Equipment, Gross $308,000 USD 20%
Operating Lease, Liability, Current $726,000 USD 38%
Lessee, Operating Lease, Liability, to be Paid, Year Two $861,000 USD 15%
Lessee, Operating Lease, Liability, to be Paid, Year One $692,000 USD 40%
Operating Lease, Weighted Average Discount Rate, Percent 0.085 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount $470,000 USD -34%
Lessee, Operating Lease, Liability, to be Paid, Year Three $942,000 USD 9.4%
Deferred Tax Assets, Operating Loss Carryforwards $45,942,000 USD 3.7%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 10,000,000 shares 0%
Unrecognized Tax Benefits $9,300,000 USD 46%
Lessee, Operating Lease, Liability, to be Paid, Year Four $665,000 USD -29%
Operating Lease, Payments $103,000 USD 61%
Preferred Stock, Shares Outstanding 0 shares
Deferred Tax Assets, Net of Valuation Allowance $79,905,000 USD -4.3%
Share-based Payment Arrangement, Expense $45,846,000 USD -54%
Preferred Stock, Par or Stated Value Per Share 0.001 USD/shares 0%